Search the record

Imposing Duties To Address the Synthetic Opioid Supply Chain in the People's Republic of China

Modifying Duties Addressing the Synthetic Opioid Supply Chain in the People's Republic of China

Amendment to Duties Addressing the Synthetic Opioid Supply Chain in the People's Republic of China

Modifying Reciprocal Tariff Rates To Reflect Discussions With the People's Republic of China

Further Amendment to Duties Addressing the Synthetic Opioid Supply Chain in the People's Republic of China

Suspension of Entry as Nonimmigrants of Certain Students and Researchers From the People's Republic of China

Addressing China's Laws, Policies, Practices, and Actions Related to Intellectual Property, Innovation, and Technology

Further Modifying Reciprocal Tariff Rates To Reflect Ongoing Discussions With the People's Republic of China

Continuation of the National Emergency With Respect to the Threat From Securities Investments That Finance Certain Companies of the People's Republic of China

Modifying Reciprocal Tariff Rates Consistent With the Economic and Trade Arrangement Between the United States and the People's Republic of China

Amendment to Reciprocal Tariffs and Updated Duties as Applied to Low-Value Imports From the People's Republic of China

Further Amendment to Duties Addressing the Synthetic Opioid Supply Chain in the People's Republic of China as Applied to Low-Value Imports

Actions by the United States Related to the Section 301 Investigation of China's Laws, Policies, Practices, or Actions Related to Technology Transfer, Intellectual Property, and Innovation

Regarding the Proposed Acquisition of Lattice Semiconductor Corporation by China Venture Capital Fund Corporation Limited